| Autor: |
Aghazadeh S; Regenerative Medicine, Department of Health Science and Technology, Aalborg University, 9260 Gistrup, Denmark., Peng Q; Regenerative Medicine, Department of Health Science and Technology, Aalborg University, 9260 Gistrup, Denmark., Dardmeh F; Regenerative Medicine, Department of Health Science and Technology, Aalborg University, 9260 Gistrup, Denmark., Hjortdal JØ; Department of Ophthalmology, Aarhus University Hospital, 8200 Aarhus, Denmark., Zachar V; Regenerative Medicine, Department of Health Science and Technology, Aalborg University, 9260 Gistrup, Denmark., Alipour H; Regenerative Medicine, Department of Health Science and Technology, Aalborg University, 9260 Gistrup, Denmark. |
| Abstrakt: |
Limbal mesenchymal stromal cells (LMSCs) reside in the limbal niche, supporting corneal integrity and facilitating regeneration. While mesenchymal stem/stromal cells (MSCs) are used in regenerative therapies, there is limited knowledge about LMSC subpopulations and their characteristics. This study characterized human LMSC subpopulations through the flow cytometric assessment of fifteen cell surface markers, including MSC, wound healing, immune regulation, ASC, endothelial, and differentiation markers. Primary LMSCs were established from remnant human corneal transplant specimens and passaged eight times to observe changes during subculture. The results showed the consistent expression of typical MSC markers and distinct subpopulations with the passage-dependent expression of wound healing, immune regulation, and differentiation markers. High CD166 and CD248 expressions indicated a crucial role in ocular surface repair. CD29 expression suggested an immunoregulatory role. Comparable pigment-epithelial-derived factor (PEDF) expression supported anti-inflammatory and anti-angiogenic roles. Sustained CD201 expression indicated maintained differentiation capability, while VEGFR2 expression suggested potential endothelial differentiation. LMSCs showed higher VEGF expression than fibroblasts and endothelial cells, suggesting a potential contribution to ocular surface regeneration through the modulation of angiogenesis and inflammation. These findings highlight the heterogeneity and multipotent potential of LMSC subpopulations during in vitro expansion, informing the development of standardized protocols for regenerative therapies and improving treatments for ocular surface disorders. |
